NOVABAY PHARMACEUTICALS INC (NBY)       2.1109  -0.19 (-8.22%)

2.1109  -0.19 (-8.22%)

US66987P2011 - Common Stock - After market: 2.11 0 (-0.04%)

NOVABAY PHARMACEUTICALS INC2.1109

NYSEARCA:NBY (11/30/2022, 7:04:00 PM)-0.19 (-8.22%)

After market: 2.11 0 (-0.04%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-14 2022-11-14/amc Earnings (Next) 03-27 2023-03-27
Ins Owners 17.81% Inst Owners 171.06%
Market Cap 3.92M Shares 1.86M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 83.33
IPO 10-26 2007-10-26

Stock Screener Links

Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NBY Daily chart

Company Profile

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 29 full-time employees. The company went IPO on 2007-10-26. The firm's lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have antimicrobial properties as it removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with its form of hypochlorous acid and is cleared by the United States Food and Drug Administration (FDA) for sale in the United States. Its other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress and the i-Chek. Avenova Spray is available both over-the-counter and as a prescription. Avenova Spray is also available at optometrists and ophthalmologists offices; at national pharmacy chains across all over 50 states, and through its Partner Pharmacy Program.

Company Info

NOVABAY PHARMACEUTICALS INC

2000 Powell St Ste 1150

Emeryville CALIFORNIA 94608

P: 15108998800.0

CEO: Justin Hall

Employees: 29

Website: http://novabay.com/

NBY News

News Image2 days ago - NovaBay® Pharmaceuticals, Inc.NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and ChinaNews Image14 days ago - NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema BalmNews Image16 days ago - Seeking AlphaNBY stock falls as company announces reverse stock split (NYSE:NBY)

NovaBay Pharmaceuticals (NBY) announced that the company’s common stock would start trading on a split-adjusted basis on Nov

News Image16 days ago - NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNews Image16 days ago - NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock SplitNews Image21 days ago - NovaBay Pharmaceuticals, Inc.NovaBay Pharmaceuticals to Hold Third Quarter 2022 Conference Call on November 14

NBY Twits

Here you can normally see the latest stock twits on NBY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example